Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,98 € ↑2,18 (3,53%)
2026-06-04
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionTrexquant Investment LP
Latest Disclosed Ownership194,041 shares
Latest Disclosed Value $ 7,821,793
Trexquant Investment LP reports 153.92% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 15, 2026 - Trexquant Investment LP filed a 13F-HR form disclosing ownership of 194,041 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $6,692,474 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 76,417 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 153.92% during the quarter. The current value of the position is $12,414,743 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 194,041 117,624 153.92 7,822 194.13 0.0562
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 76,417 76,417 2,659 0.0237
2025-05-14 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -65,113 -100.00 0 -100.00
2025-02-12 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 65,113 65,113 3,281 0.0382
2024-11-12 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -100,615 -100.00 0 -100.00
2024-08-13 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 100,615 -70,851 -41.32 3,269 -24.33 0.0499
2024-05-14 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 171,466 110,948 183.33 4,319 119.80 0.0861
2024-02-09 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 60,518 -15,254 -20.13 1,966 -4.80 0.0442
2023-11-13 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 75,772 3,481 4.82 2,064 28.36 0.0518
2023-08-11 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 72,291 72,291 1,608 0.0422
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -66,046 -100.00 0 -100.00
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 66,046 48,917 285.58 1,341 205.47 0.0380
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 17,129 -39,976 -70.00 439 -67.67 0.0154
2022-08-11 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 57,105 2,658 4.88 1,358 10.77 0.0608
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 54,447 5,382 10.97 1,226 26.26 0.0576
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 49,065 36,833 301.12 971 302.90 0.0600
2021-11-12 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 12,232 12,232 241 0.0191
2021-02-11 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -61,875 -100.00 0 -100.00
2020-11-06 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 61,875 35,745 136.80 1,077 144.77 0.0693
2020-08-07 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 26,130 26,130 440 0.0306
2020-05-08 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -11,608 -100.00 0 -100.00
2020-02-12 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 11,608 11,608 140 0.0083
2019-05-13 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -59,868 -100.00 0 -100.00
2019-02-13 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 59,868 45,196 308.04 800 288.35 0.0500
2018-11-09 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 14,672 -4,117 -21.91 206 -30.17 0.0155
2018-08-07 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 18,789 -24,899 -56.99 295 -58.97 0.0204
2018-05-03 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 43,688 43,688 719 0.0501
2017-08-01 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -18,400 -100.00 0 -100.00
2017-05-08 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 18,400 18,400 202 0.0259
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.